Clinical Trial Update: Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase II trial update of short-term adjuvant therapy and biomarker studies using targeted agents in women with estrogen receptor-negative breast cancer; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor Negative Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-07-10